Sign In
Buy VTRS
$16.39
+0.120 (+0.738%)
At Close: Jul 13, 2026
3 Beaten-Down Dividend Stocks That Look Like Bargains Right Now
05:12am, Monday, 10'th Jul 2023
Viatris is a generic drugmaker formed from a merger between Pfizer's generic drug division and Mylan. CVS Health is famous for its pharmacy chain, but it's the parts of its business you might not know
3 Stocks to Snag for Less Than Book Value
09:24am, Friday, 07'th Jul 2023
The move to share repurchases over the last few years has made the price-to-book ratio less reliable for finding hidden opportunities in stocks. How's that, you ask?
Why Dividend Stocks Should Be a Key Part of Your Retirement Plan
07:15am, Friday, 07'th Jul 2023
If you worry you won't have enough saved up by retirement, dividend stocks can help boost your income. Allocating part of your retirement savings to such equities can reduce depletion of your savings.
Wall Street Thinks Viatris Stock Will Rise 25% -- Could It Grow Even More?
06:08am, Wednesday, 05'th Jul 2023
Viatris is growing while slashing costs and returning capital to investors. It has plans to onboard even more new sources of revenue, but it'll take a while.
Viatris to Report Second Quarter 2023 Financial Results on August 7, 2023
11:45am, Wednesday, 28'th Jun 2023
PITTSBURGH , June 28, 2023 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) plans to report its second quarter 2023 financial results on Monday, August 7 before the open of the U.S. financial markets. C
Fresh Blood: 3 Stocks Ready to Rally Under New CEOs
07:00am, Wednesday, 28'th Jun 2023
In recent years, S&P 500 companies with new chief executive officers (CEOs) have become a regular occurrence. That's because CEOs are moving on more quickly — both by choice and because of activist
Viatris (VTRS) Flat As Market Gains: What You Should Know
07:34pm, Tuesday, 27'th Jun 2023
Viatris (VTRS) closed the most recent trading day at $9.85, making no change from the previous trading session.
Barclays Downgrades Viatris
10:25pm, Friday, 23'rd Jun 2023
Fintel reports that on June 23, 2023, Barclays downgraded their outlook for Viatris (NASDAQ:VTRS) from Equal-Weight to Underweight.
The Wonders of Shareholder Yield
11:43am, Friday, 16'th Jun 2023
Shareholder Yield is a composite metric which measures potential shareholder returns. Many investors are not terribly familiar with this metric, preferring to pay attention to dividends alone.
Viatris: Won't Take Much To Move The Needle
12:37pm, Thursday, 15'th Jun 2023
Viatris remains a dirt cheap stock in a frothy market and pays a well-covered dividend yield. It continues to make progress towards deleveraging, and could return substantial capital to shareholders i
Viatris Inc. (VTRS) Goldman Sachs 44th Annual Global Healthcare Conference (Transcript)
06:36pm, Tuesday, 13'th Jun 2023
Viatris Inc. (NASDAQ:VTRS ) Goldman Sachs 44th Annual Global Healthcare Conference June 13, 2023 4:20 PM ET Company Participants Scott Smith - CEO Rajiv Malik - President Sanjeev Narula - CFO Conferen
These 2 Dividend Stocks Yield 5% -- and They Aren't Risky Buys
08:08am, Thursday, 08'th Jun 2023
Viatris generates ample cash flow to pay down its debt and support its above-average dividend yield. Enbridge's payout ratio based on net income may look alarming, but the company's dividend is safer
Why Is Viatris (VTRS) Down 2.4% Since Last Earnings Report?
12:34pm, Wednesday, 07'th Jun 2023
Viatris (VTRS) reported earnings 30 days ago. What's next for the stock?
Looking for Passive Income at a Decent Price? Buy These 2 Stocks
05:05am, Monday, 05'th Jun 2023
High-quality dividend stocks typically aren't cheap. Viatris has a great roster of medicines on the market, with more generics to come.
Our acquisition of Viatris business has been 'spooking the Indian investor,' biotechnology firm says
01:11am, Thursday, 25'th May 2023
Kiran Mazumdar-Shaw of Biocon & Biocon Biologics discusses the company's acquisition of Viatris' biosimilars business and says Indian investors are "very wary" of overseas acquisitions and there was a
